Artificial Intelligence in Clinical Trials Market to Hit US$ 2.74 Billion by 2030 with 12.4% CAGR | MarketsandMarkets™.
The global artificial intelligence in clinical trials market , valued at US$1.20 billion in 2023, is forecasted to grow at a ...
Vir Biotechnology’s Early Promise in Clinical Trials Warrants Hold Rating Amid Uncertainties
Morgan Stanley analyst Michael Ulz maintained a Hold rating on Vir Biotechnology (VIR – Research Report) today and set a price target of ...
Cassava Sciences issues layoffs, regroups after failed drug study
An Austin biotech company is laying off a third of its staff following news that its primary drug candidate didn't produce ...
Arabian Business20h
Abu Dhabi’s IROS to collaborate in clinical study on obesity treatment
US-based Halia Therapeutics’ new therapy will be put to a six-month-long trial that will involve 60 patients with type 2 ...
Zawya1d
M42’s IROS and Halia Therapeutics launch clinical study on obesity treatment in the UAE
IROS and Halia Therapeutics’ clinical trial will explore a promising new therapy for obesity, specifically designed to ...
TipRanks on MSN10d
How to Pick a Winner: A Guide to Investing in Clinical-Stage Biotechs
In response to a recent article about an interesting biotechnology stock, a reader recently asked me how to handle the ...
Vir Biotechnology’s Early Stage Developments and Valuation Lead to Hold Rating Amid Long-Term Promise and Near-Term Uncertainties
Eric Joseph, an analyst from J.P. Morgan, maintained the Hold rating on Vir Biotechnology (VIR – Research Report). The associated price target ...
Pharmaceutical Technology3d
Obudanersen sodium by Ionis Pharmaceuticals for Angelman Syndrome: Likelihood of Approval
Obudanersen sodium is under clinical development by Ionis Pharmaceuticals and currently in Phase II for Angelman Syndrome.
AI in Clinical Trials Market Research 2024-2030 with In-depth Assessment of Market Shares, Growth Strategies, and Service Offerings of Leading Players
The "AI in Clinical Trials Market by Function, Phase, Indication, Tool, End-User & Region - Global Forecast to 2030" report ...
Pharmaceutical Technology3d
Dofetilide by Hyloris Pharmaceuticals for Atrial Flutter: Likelihood of Approval
Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter.
Brand Featured: Non-Profit Organization A Race Against Blindness Donates $1 Million to Bardet-Biedl Syndrome Research
A Race Against Blindness, an Arizona-based nonprofit organization, has awarded a $1 million grant to fund research and clinical trials focused on ...
The Straits Times23d
China approves mpox vaccine for clinical trials
In China, a vaccine candidate typically goes through three phases of clinical trials before gaining ... Another mpox vaccine candidate under research is developed by the Shanghai Institute of ...